Roya Khosravi-Far
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Oncology, Molecular Biology, PathologyGoogle:
"Roya Khosravi-Far"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bucur O, Stancu AL, Muraru MS, et al. (2020) PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor. Discoveries (Craiova, Romania). 2 |
Esposti MD, Matarrese P, Tinari A, et al. (2017) Changes in membrane lipids drive increased endocytosis following Fas ligation. Apoptosis. 22: 681-695 |
Bucur O, Gaidos G, Yatawara A, et al. (2015) A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death. Scientific Reports. 5: 9893 |
Gunda V, Bucur O, Varnau J, et al. (2014) Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways. Cell Death and Disease. 5 |
Sandra F, Khosravi-Far R. (2014) Ser81 Survivin Induced Protein Kinase A (PKA)-dependent Phosphatidylinositol 3-kinase (PI3K) Activity The Indonesian Biomedical Journal. 6: 157 |
Pennarun B, Gaidos G, Bucur O, et al. (2013) killerFLIP: a novel lytic peptide specifically inducing cancer cell death. Cell Death & Disease. 4: e894 |
Bucur O, Stancu AL, Goganau I, et al. (2013) Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells. Plos One. 8: e77390 |
Nadler M, Zabolian R, Ndebele K, et al. (2013) Abstract 3058: miRNA networks mediate the tumor suppressive function of FOXO proteins. Cancer Research. 73: 3058-3058 |
Gunda V, Bucur O, Varnau J, et al. (2013) TRAIL Induced Apoptosis is Enhanced by Inhibition of the MAPK and PI3K/AKT Pathways in Thyroid Cancer Cells Journal of Surgical Research. 179: 244 |
Bucur O, Stancu AL, Khosravi-Far R, et al. (2012) Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death & Disease. 3: e263 |